Search Results - M. N. Mamedov

Refine Results
  1. 1
    THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOLOGY 2015

    THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOLOGY 2015 by M. N. Mamedov

    Published 2015-10-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    INTERNATIONAL DIABETES FEDERATION CONSENSUS ON DEFINITION OF THE METABOLIC SYNDROME: FACTS AND COMMENTS

    INTERNATIONAL DIABETES FEDERATION CONSENSUS ON DEFINITION OF THE METABOLIC SYNDROME: FACTS AND COMMENTS by M. N. Mamedov

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Impaired glucose tolerance: who and how treats it?

    Impaired glucose tolerance: who and how treats it? by M. N. Mamedov

    Published 2005-12-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    INDAPAMIDE POTENTIAL AT VARIOUS STAGES OF CARDIOVASCULAR CONTINUUM AND IN SPECIFIC CLINICAL GROUPS

    INDAPAMIDE POTENTIAL AT VARIOUS STAGES OF CARDIOVASCULAR CONTINUUM AND IN SPECIFIC CLINICAL GROUPS by M. N. Mamedov

    Published 2010-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    MAGNESIUM MEDICATION USE IN CARDIOLOGY PRACTICE

    MAGNESIUM MEDICATION USE IN CARDIOLOGY PRACTICE by M. N. Mamedov

    Published 2012-04-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Reviewing proceedings of the II International Conference “Metabolic Syndrome and Dyslipidemia”, New York: how to adapt largeD scale studies' results to realDworld clinical settings in Russia?

    Reviewing proceedings of the II International Conference “Metabolic Syndrome and Dyslipidemia”, New York: how to adapt largeD scale studies' results to realDworld clinical settings... by M. N. Mamedov

    Published 2005-10-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Metabolic effects of antihypertensive medications: prognostic role in the development of cardiovascular disease and diabetes mellitus

    Metabolic effects of antihypertensive medications: prognostic role in the development of cardiovascular disease and diabetes mellitus by M. V. Stroeva, M. N. Mamedov

    Published 2010-04-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS

    METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS by E. I. Yakovenko, M. N. Mamedov

    Published 2012-04-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    EARLY DISTURBANCES OF CARBOHYDRATE METABOLISM — A TARGET FOR PRIMARY CARDIOVASCULAR PREVENTION

    EARLY DISTURBANCES OF CARBOHYDRATE METABOLISM — A TARGET FOR PRIMARY CARDIOVASCULAR PREVENTION by M. N. Kovrigina, M. N. Mamedov

    Published 2013-04-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue

    Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue... by G. G. Arabidze, M. N. Mamedov

    Published 2024-06-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Relationship between microplastics and cardiovascular risk factors

    Relationship between microplastics and cardiovascular risk factors by M. N. Mamedov, E. A. Savchuk

    Published 2024-07-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Prospects for the use of anti-inflammatory therapy in patients with coronary artery disease

    Prospects for the use of anti-inflammatory therapy in patients with coronary artery disease by N. M. Abduzhamalova, M. N. Mamedov

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES

    CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES by M. N. Mamedov, O. M. Drapkina

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    MARKERS OF ACCELERATED CONVERSION OF DIABETES MELLITUS IN VARIOUS CARDIOVASCULAR RISK PATIENTS

    MARKERS OF ACCELERATED CONVERSION OF DIABETES MELLITUS IN VARIOUS CARDIOVASCULAR RISK PATIENTS by M. N. Mamedov, M. N. Korneeva

    Published 2016-12-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Risk factors and psychosomatic status among the military population of Azerbaijan with coronary artery disease

    Risk factors and psychosomatic status among the military population of Azerbaijan with coronary artery disease by A. E. Masimova, M. N. Mamedov

    Published 2021-03-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    REPORT ON III INTERNATIONAL FORUM OF CARDIOLOGY AND INTERNAL MEDICINE, MARCH 24-26, 2014, MOSCOW

    REPORT ON III INTERNATIONAL FORUM OF CARDIOLOGY AND INTERNAL MEDICINE, MARCH 24-26, 2014, MOSCOW by R. G. Oganov, M. N. Mamedov

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    In memory of Professor Natalia V. Perova (08/12/1939 — 12/20/2023)

    In memory of Professor Natalia V. Perova (08/12/1939 — 12/20/2023) by V. A. Metelskaya, M. N. Mamedov

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Risk factors for cardiovascular diseases and coronary artery disease among military population

    Risk factors for cardiovascular diseases and coronary artery disease among military population by A. E. Masimova, M. N. Mamedov

    Published 2021-02-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL

    WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL by M. N. Mamedov, M. B. Stroeva

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK

    ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK by M. N. Kovrigina, M. N. Mamedov

    Published 2015-12-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: